Endocrine Pathology
Endocrine Pathology
Endocrine Pathology
1. ANTERIOR Pituitary :
Secretes trophic hormones (trophic mean target another gland to secrete another
hormone)
Acidophil cells (pink in color); somatotroph, prolactin
Basophil cells (blue in color); corticotroph, gonadotroph, thyrotroph.
Under influence of feedback; +ve from hypothalamus and -ve from the body.
Most are stimulatory factors except for prolactin.
Most diseases arise from the pituitary itself (not hypothalamus)
FUNCTIONING Abnormality :
A) Hyperpituitarism :
B) Hypopituitarism :
29
Pituitary adenoma :
29
Pathogenesis :
- Mutation in G-proteins that transmit a signal transduction to intracellular
effectors (adenyl-cyclase), generating 2nd messengers cAMP, a potent
mitogenic factor.
- Normally, G-proteins are activated upon ligand binding.
- Mutant G-proteins have autonomous, permanent activity (activation
without ligand).
A) Prolactinoma
Most common PA.
Cau
ses
29
2. POSTERIOR Pituitary
Causes :
Associated with hyperthyroidism
Primary :
1) Diffuse toxic hyperplasia (Graves
Diseasea)
2) Hyper-functioning (toxic)
multinodular goiter
3) Hyper-functioning (toxic) adenoma
Secondary :
1) TSH-secreting pituitary adenoma
rare
29
1)
2)
3)
4)
Symptoms :
- Heat intolerance, excessive sweating.
- Skin: soft, flushed, warm
- Muscles (characteristic): proximal upper and lower muscle weakness.
- Cardiac (most dangerous): arrhythmia, palpitation.
- GIT: soft diarrhea, malabsorption, weight loss.
- Nervousness, irritability, increased sympathetic stimulation, tremor.
Ocular: lid lag, wide staring eyes (most obvious in Graves disease)
ost obvious in Graves disease, secondary to accumulation of soft tissue behind the eye globes
B) Hypothyroidism :
Primary
1) Post-ablative: surgery, radioiodine therapy or external radiation.
2) Hashimoto thyroiditis*
3) Iodine deficiency*
4) Dyshormonogenetic goiter (Congenital biosynthetic defect)*
5) Drugs: lithium, iodides, p-aminosalicyclic acid*
6) Thyroid dysgenesis (Rare developmental abnormalities of the thyroid)
29
29
Pathogenesis
- Progressive depletion of epithelial cells, replaced by inflammatory cells
(lymphocytes and plasma cells).
- Abnormality begin with; Autoreactive CD4+ T-lymphocytes against normal
thyroid antigens produces INF- Recruitment of macrophages, CD8+ T
lymphocytes, causing damage to epithelium.
- Also activate plasma cells of B-lymphocyte to synthesize auto antibodies
(diagnosis by the AB)
- Genetic predisposition (not hereditary): family history, HLA-DR3, HLA-DR5
Clinical
- Painless goiter
- Initial transient phase of thyrotoxicosis. Followed by gradual, progressive
hypothyroidism.
- Risk of B-cell lymphomas but NOT thyroid carcinoma.
- Other autoimmune diseases are common (like; lopus arthritis, immune
gastritis, )
Morphology
- Grossly: diffuse enlargement of thyroid gland, Intact capsule, Not
adherent to adjacent structures.
- Micro: dense infiltration of B-lymphocyte (forming germinal centers),
plasma cells, T-lymphocytes and macrophages.
- Follicular epithelium is atrophic, show metaplastic changes into larger, pink
cuboidal cells (full of mitochondria) called HURTHLE CELLS or OXYFIL CELLS
- With disease advance: fibrosis and atrophy.
Graves disease
males.
Triad: thyrotoxicosis, ophthalmopathy, localized infiltrative dermatopathy
diseases
Transient episodes of hypothyroidism within the course of the disease.
Pathogenesis
-
29
a) Thyroid-stimulating immunoglobulin (TSI): most important, autoAB that binds TSH receptor and mimics action of TSH, stimulating
adenylyl cyclase, results in secretion of thyroid hormones (specific)
b) Thyroid growth-stimulating immunoglobulins (TGI): another AB
against TSH receptor, stimulates proliferation of follicular epithelium =
goiter
c) TSH-binding inhibitor immunoglobulins (TBII): prevents TSH from
normal binding to its receptor and:
I. stimulates proliferation of follicular epitheliem,
II. other forms inhibit thyroid function (coexist)
Thats why graves disease may have episode of hypothyroidism.
d) Anti-thyroglobulin, anti-thyroid peroxidase Abs (not specific)
related to hashimito dis.
Infiltrative ophthalmopathy :
-
29
Increased size of extra orbital muscles and retro orbital soft tissue causing
exophthalmos by:
a) Infiltration by inflammatory cells
b) Inflammatory edema
c) Accumulation of extracellular matrix (hyaluronic acid and chondroitin
sulfate)
d) Increased fat cells
Exophthalmos is irreversible even post treatment
Morphology:
- Diffuse goiter, soft, non-adherent, intact capsule
- Micro: follicular epithelial cells are hyperplastic (tall columnar, crowded
formation of small papillae, project into follicular lumen, lack fibrovascular
cores)
- Colloid is pale, scalloped margins
- Lymphoid infiltrate in between the cells (T > B-cells & plasma cells),
germinal centers
- Skin: edema, lymphocytes, glycosaminoglycans (hyaluronic acid and
chondroitin sulfate)
29
Riedel thyroiditis
Palpation thyroiditis :
29
29
Clinical :
- The main complaint is mass in the neck (cosmetic, stridor, dysphagia,
compression of vessels)
- Not adherent
- Plummer syndrome: when toxic nodule produces hyperthyroidism (no
ocular disease)
- Some patients have hypothyroidism
- So, it can be euthyroid, hyperthyroidism or hypothyroidism.
Morphology :
- Early: diffuse goiter, similar to Graves disease
- When euthyroid status is reached, TSH decreases, follicular epithelium
becomes small and flat, with predominance of colloid (colloid nodule).
- Normally: follicular epithelial cells are heterogeneous in response to TSH
(some respond more than others)
- With repeated attacks, proliferation is variable, fibrosis, hemorrhage, cystic
degeneration, calcification goiter is irregular (multinodular goiter)
- Some nodules become dominant & secrete excess hormones (toxic nodule)
- Both mono & polyclonal nodules are present.
29
Pathogenesis :
a) Activating mutation in TSH receptor or -subunit causing overproduction of
cAMP cell growth and mitosis
Rarely, can be functional and produce hyperthyroidism
b) 20% of cases have RAS mutation (also present in 50% of carcinoma)
Morphology :
- Solitary, well demarcated mass with intact, thin capsule (not present in
hyperplastic nodules)
- Micro: uniform follicles contain colloid distinct from the rest of thyroid, cells
are uniform
- If follicular cells show Hurthle cell change, called Hurthle cell adenoma
- Atypia might be present, but does not mean malignancy (Atypia is normally
common in endocrine system)
- If capsular invasion is present follicular carcinoma
Thy
roid
Carcinoma :
A) PAPILLARY CARCINOMA
o
o
o
o
o
o
o Pathogenesis
- 2 pathways, end by activating mitogen activating protein (MAP) kinase
signaling pathway:
I. of patient have BRAF gene mutation activating MAP.
29
II.
B) FOLLICULAR CARCINOMA
o
Second most common carcinoma (10- 20%)
Older age than PTC.
Associated with; iodine deficiency & RAS mutation in 50%
Micro: normal looking follicles, may see Hurthle cells, capsular or
lymphovascular invasion.
Evaluating the integrity of the capsule is critical in distinguishing follicular
adenomas from follicular carcinomas.
o Clinically similar to MNG
o
o
o
o
29
o Morphology
- Solitary tumor (sporadic) or multiple (familial)
- Micro: polygonal or spindle cells.
- Secrete amyloid (derived from calcitonin), positive for congo-red stain
- C-cell hyperplasia is in non-tumorous areas
- Electron microscopy: membrane bound granules containing calcitonin.
29
D) ANAPLASTIC CARCINOMA
Rare disease (<5% )
Old age
History of multinodular goiter or PTC
P53 mutation
Very aggressive (one of the worst
carcinoma)
o Rapid growth and death within a year
o Cells are large, epithelioid or spindle,
pleomorphic
o
o
o
o
o
PRIMARY HYPERPARATHYROIDISM :
29
Very common
Causes silent hypercalcemia (in contrast to cancer) , incidentally finding.
80% of cases are secondary to adenoma (in one of the 4 parathyroid the rest
are atrophic),
15% hyperplasia (four glands), 5% carcinoma.
95% cases are sporadic, 5% familial (MEN)
Familial hypocalciuric hypercalcemia: rare disease, mutation in Ca sensing
receptor on parathyroid gland, leading to constitutive secretion of PTH.
Pathogenesis
- Parathyroid adenomatosis gene1 (PRAD1), cyclin gene.
- Cyclin D1 (another cyclin) in adenoma, hyperplasia and carcinoma.
- MEN1 gene (tumor suppressor) it mutation lead easy tumor progression.
Morphology
- Under the microscope they are identical, different in; how many gland
affected & weight.
- Adenoma: single large glands, the rest are atrophic, composed
predominantly of Chief cells, may show atypia, weight 0.5-5 gm
- Hyperplasia: more than one gland, chief cells, the combined weight usually
less than 1 g
- Carcinoma: single, adherent to neck, shows invasion, metastasis, weight
>5 g
SECONDARY HYPERPARATHYROIDISM :
29
HYPOPARATHYROIDISM
Rare
Results from surgical removal, congenital absence, autoimmune, fungal
infection
Patients develop hypocalcemia (muscle weakness, neuromuscular
abnormality)
29
Promote amino acid uptake into muscles & protein synthesis, inhibit
degradation
Promote DNA synthesis, cell growth & differentiation
In fasting state, insulin is low
Type 1 DM
Type 2 DM
29
Thliazolinediones drug family activates PPAR gene in fat cells & reverse the
abnormalities
FFA & hyperglycemia adversely affects -cells both qualitatively (loss of
normal response to glucose ingestion) and quantitatively (loss of -cells &
deposition of islet cell amyloid (amilin)
29
Monogenic DM :
A single genetic mutation causing DM (in contrast to most cases of types 1,2
are genetically complex (multiple susceptible foci)
Rare
Either affect -cell function (MODY genes) or cellular insulin signaling
Other causes of DM
Loss of pancreatic tissue (carcinoma, fibrosis)
Increased hormones antagonizing insulin: (GH, cortisol, glucagon, thyroxin,
adrenalins)
CMV, Coxsackie B pancreatitis
Syndromes: Down, Kleinfelter, Turner
Gestational diabetes (increased insulin requirement on a background of
resistance)
Drugs; -agonists (causing hyperglycemia)
Effect of hyperglycemia:
1. Non-enzymatic glycosylation of proteins (sticking or adhering of
glucose to protein)
a) Glycated hemoglobin (HgA1C): reflects history and degree of
hyperglycemia, because normally there is a low element of glycation,
which will rise in DM patient to >6% of total Hb, more rising the worse is
the hyperglycemia.
b) Glycated extracellular matrix in vessels: collagen will have permanent
changes (cross linking), called advanced glycosylation end products
(AGEs), causing entrapment of plasma proteins (lipoproteins), causing
accelerated atherosclerosis.
c) In renal glomeruli, glycated basement membrane becomes thickened &
entraps albumin.
29
29
A) Insulinoma
29
B) Gastrinoma
C) Glucagonoma
-cell tumor
Increased serum glucagon resulting in mild diabetes.
Most common in peri & post-menopausal women
Commonly have characteristic skin rash (necrolytic migratory erythema)
mostly in face, U-limb
Unknown cause, a theory; deficiency in nutrient secondary to increase
glucagon mostly the zinc.
Similar histology to insulinoma
29
Cushing syndrome
o
o
o
o
Ectopic ACTH :
o Paraneoplastic syndrome
1. Small cell carcinoma of lung (most common)
2. Carcinoid
3. Medullary thyroid carcinoma.
4. Islet cell tumor of pancreas.
5. Ectopic corticotrophin releasing hormone (CRH)
Morphology
o Pituitary gland: Crooke hyaline change or Crooke bodies: homogenous light
basophilic intracytoplasmic material, composed of intermediate keratin
filaments. The normal granular basophilic cytoplasm of corticotroph cells is
lost due continuous negative feedback.
o Exogenous or ectopic cortisol: bilateral cortical atrophy in adrenals
(atrophy of fasciculata & reticularis)
o Adrenal hyperplasia: diffuse thickening of the cortex, may show multiple &
bilateral 0.5-2cm nodules (nodular hyperplasia). Combined adrenal weight
30-50 g
29
Adrenocortical adenoma :
29
Adrenocortical carcinoma
Primary hyperaldosteronism :
29
Secondary hyperaldosteronism
Adrenal androgens are under the influence of ACTH (in contrast to gonads)
Increased production, with virilization, is commonly seen in adrenocortical
neoplasms (especially carcinoma) because some of the increased cortisol will
turn to androgens.
29
Adrenal insufficiency
1.
2.
3.
Pheochromocytoma :
Micro: zellballen pattern (small balls), finely granular cytoplasm positive for
silver stain.
29
29
Autosomal Dominant.
The patient born with single mutation, later in life, Inactivation of both alleles
of MEN1 gene, located on 11q13 (tumor suppressor gene) then the symptom
start.
Multiple parathyroid hyperplasia (95%)
Pancreas (40%), often functional (insulinoma, gastrinoma), fatal
hypoglycemia, behave aggressively with metastasis
2) MEN type 2
29